Novel Nutraceutical Supplement

**Novel Nutraceutical Supplement** is an investigational oral multi-ingredient nutraceutical supplement studied in overweight and obesity-related metabolic dysfunction. In the cited randomized double-blind clinical trial and associated translational program, it refers specifically to the silymarin-containing formulation composed of fructooligosaccharides, galactooligosaccharides, yeast beta-glucans from *Saccharomyces cerevisiae*, zinc, magnesium, selenomethionine, tixosil, and *Silybum marianum* extract. It is intended to act through complementary nutritional, prebiotic, immunomodulatory, antioxidant, and hepatoprotective effects rather than a single defined pharmacologic target, with proposed effects on obesity-associated endocrine and metabolic parameters and biomarkers linked to nonalcoholic fatty liver disease. The program appears to have been developed in an academic-industry setting involving the University of Sao Paulo General Hospital and Efeom Nutrição, with capsule administration at 4 capsules daily for 180 days in the reported human study.

Other names

Novel Nutraceutical SupplementComposition with Silymarin